Medications

FDA asked to consider party drug MDMA as treatment for PTSD

A California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stress disorder (PTSD).

Medical economics

How a novel model resolves the key pandemic policy debates

Were lockdowns an effective response to COVID-19 or would it have been better to limit intervention and let individuals spontaneously reduce their own risk of infection? Three years on from the public health emergency that ...

page 2 from 13